Chemically Modified AsCas12a Guide RNAs Improve Lipid Nanoparticle-Mediated In Vivo Gene Editing in Different Tissues

被引:0
|
作者
Wrighton, Paul J. [1 ]
Newmark, Judith [1 ]
Latrick, Chrysa [1 ]
Soman, Vikram [1 ]
Pinilla, Andrea [1 ]
Jones, Mark [1 ]
Quenzer, Eleanor [1 ]
Miller, Alison [1 ]
Bottega, Steve [1 ]
Benedis, Alexis [1 ]
Chica, Bryant [1 ]
Moffet, Bridget [1 ]
Wu, Meng [1 ]
Marco, Eugenio [1 ]
Lele, Swarali [1 ]
Viswanathan, Ramya [1 ]
Wang, He [1 ]
Sun, Xiaoqi [1 ]
Zuris, John A. [1 ]
Bochicchio, James [1 ]
Delano, Kayla [1 ]
Giannoukos, Georgia [1 ]
Chang, Kai-Hsin [1 ]
Pietrasiewicz, Stephen [1 ]
Allocca, Mariacarmela [1 ]
MacLeod, Heather [1 ]
Wolk, Steven [1 ]
机构
[1] Editas Med, Cambridge, MA USA
关键词
D O I
暂无
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
1182
引用
收藏
页码:563 / 563
页数:1
相关论文
共 16 条
  • [1] Gold Nanoparticle-Mediated Gene Editing for Long Transgene Delivery In Vivo
    Cunningham, Rachel
    Gottimukkala, Karthikeya S. V.
    Lane, Daniel D.
    Cassidy, Molly E.
    Bayigga, Lois
    Jwa, Youngseo
    Castelli, Jack M. P.
    Taylor, Justin J.
    Adair, Jennifer E.
    MOLECULAR THERAPY, 2023, 31 (04) : 754 - 755
  • [2] Quantifying lipid nanoparticle-mediated gene editing and morphological changes in murine retinal pigmented epithelium
    Su, Grace Li-Na
    Eygeris, Yulia
    Curtis, Allison G.
    Jozic, Antony
    Gautam, Milan
    Henderson, Michael
    Sahay, Gaurav
    Ryals, Renee Christine
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2024, 65 (07)
  • [3] Lipid nanoparticle-mediated intracameral mRNA delivery facilitates gene expression and editing in the anterior chamber of the eye
    Vasudevan, Aishwarya
    Jozic, Antony
    Curtis, Allison G.
    Bodi, Emily
    Ryals, Renee C.
    Sahay, Gaurav
    JOURNAL OF CONTROLLED RELEASE, 2025, 379 : 1022 - 1028
  • [4] Lipid nanoparticle-mediated CRISPR/Cas9 gene editing and metabolic engineering for anticancer immunotherapy
    Ju, Hyemin
    Kim, Dongyoon
    Oh, Yu-Kyoung
    ASIAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2022, 17 (05) : 641 - 652
  • [5] Lipid nanoparticle-mediated CRISPR/Cas9 gene editing and metabolic engineering for anticancer immunotherapy
    Hyemin Ju
    Dongyoon Kim
    Yu-Kyoung Oh
    Asian Journal of Pharmaceutical Sciences, 2022, 17 (05) : 641 - 652
  • [6] Comparative analysis of lipid Nanoparticle-Mediated delivery of CRISPR-Cas9 RNP versus mRNA/sgRNA for gene editing in vitro and in vivo
    Walther, Johanna
    Porenta, Deja
    Wilbie, Danny
    Seinen, Cornelis
    Benne, Naomi
    Yang, Qiangbing
    de Jong, Olivier Gerrit
    Lei, Zhiyong
    Mastrobattista, Enrico
    EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS, 2024, 196
  • [7] In Vivo Prime Editing by Lipid Nanoparticle Co-Delivery of Chemically Modified pegRNA and Prime Editor mRNA
    Chen, Zexiang
    Kelly, Karen
    Cheng, Haoyang
    Dong, Xiaolong
    Hedger, Adam K.
    Li, Li
    Sontheimer, Erik J.
    Watts, Jonathan K.
    GEN BIOTECHNOLOGY, 2023, 2 (06): : 490 - 502
  • [8] Lipid Nanoparticle-Mediated Hit-and-Run Approaches Yield Efficient and Safe In Situ Gene Editing in Human Skin
    Bolsoni, Juliana
    Liu, Danny
    Mohabatpour, Fatemeh
    Ebner, Ronja
    Sadhnani, Gaurav
    Tafech, Belal
    Leung, Jerry
    Shanta, Selina
    An, Kevin
    Morin, Tessa
    Chen, Yihang
    Arguello, Alfonso
    Choate, Keith
    Jan, Eric
    Ross, Colin J. D.
    Brambilla, Davide
    Witzigmann, Dominik
    Kulkarni, Jayesh
    Cullis, Pieter R.
    Hedtrich, Sarah
    ACS NANO, 2023, 17 (21) : 22046 - 22059
  • [9] Lipid nanoparticle-mediated codelivery of Cas9 mRNA and single-guide RNA achieves liver-specific in vivo genome editing of Angptl3
    Qiu, Min
    Glass, Zachary
    Chen, Jinjin
    Haas, Mary
    Jin, Xin
    Zhao, Xuewei
    Rui, Xuehui
    Ye, Zhongfeng
    Li, Yamin
    Zhang, Feng
    Xu, Qiaobing
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2021, 118 (10)
  • [10] Efficient In utero RNA lipid nanoparticle-mediated gene editing for correction of type 1 tyrosinemia without the AAV-associated genotoxicity
    Singh, K.
    Riley, R.
    Kashyap, M.
    White, B.
    Bose, S.
    Li, H.
    Dave, A.
    Palanki, R.
    Billingsley, M.
    Coons, B.
    Riley, J.
    Zoltick, P.
    Everett, J.
    Roche, A.
    Bushman, F.
    Musunuru, K.
    Mitchell, M.
    Peranteau, W.
    HUMAN GENE THERAPY, 2021, 32 (19-20) : A68 - A68